Apo-semaglutide Injection : Incorrect Dose Display
Apo-Semaglutide Injection Recall Apo-Semaglutide Injection is being recalled across Canada because the dose display on the pen may show an incorrect amount. This is a Class II recall, meaning the product could cause adverse health effects. The recall affects all Apo-Semaglutide Injection products distributed in Canada.
- Product
- Apo-Semaglutide Injection
- Reason
- Product quality concern
- Classification
- Class II
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-09-24
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/6c8ac749-355e-4d88-bd2d-350c3298c6ae